Crossref
HBeAg Negativity is Associated with a Higher Risk of Liver-Related Death in Patients with Chronic Hepatitis B Related Liver Cirrhosis
Diseases and Research · 2022
DOI: 10.54457/dr.20220004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases and Research, 2022. Verfasst von Jian Wang und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, J., Yin, S., Zhu, L., Liu, J., Xue, R., Geng, Y., Xia, J., Xiong, Y., Wu, W., Tong, X., Yan, X., Chen, Y., Zhu, C., Huang, R., & Wu, C. (2022). HBeAg Negativity is Associated with a Higher Risk of Liver-Related Death in Patients with Chronic Hepatitis B Related Liver Cirrhosis. Diseases and Research. https://doi.org/10.54457/dr.20220004
Vancouver
Wang J, Yin S, Zhu L, Liu J, Xue R, Geng Y, et al. HBeAg Negativity is Associated with a Higher Risk of Liver-Related Death in Patients with Chronic Hepatitis B Related Liver Cirrhosis. Diseases and Research. 2022. doi:10.54457/dr.20220004
BibTeX
@article{Wang2022,
author = {Wang, Jian and Yin, Shengxia and Zhu, Li and Liu, Jiacheng and Xue, Ruifei and Geng, Yu and Xia, Juan and Xiong, Yali and Wu, Weihua and Tong, Xin and Yan, Xiaomin and Chen, Yuxin and Zhu, Chuanwu and Huang, Rui and Wu, Chao},
title = {HBeAg Negativity is Associated with a Higher Risk of Liver-Related Death in Patients with Chronic Hepatitis B Related Liver Cirrhosis},
journal = {Diseases and Research},
year = {2022},
doi = {10.54457/dr.20220004}
}
EUVIMED